MarketCap
Facebook
X
Telegram
Cardinal Health Balance Sheet 2025-2011 | CAH
Brief overview of Cardinal Health's financial position
Balance sheet changes are traced across five available annual reports between 2015 and 2019.
Assets added +35.9%, reaching $41 billion from $30.1 billion five periods earlier; annual growth near 8% remained solid.
Funding shifted toward liabilities: they gained +45%, compared with +35.9% for assets.
Internal capital represents 15.4% of the balance sheet versus 20.8% five periods ago. The cushion is thin.
Net debt reached $5.5 billion, equal to 0.87x of equity. The debt profile is moderately stretched.
Cash represents 6.2% of assets versus 15.3% initially, showing how the immediate liquidity reserve changed.
Retained earnings reached $5.4 billion, changing -1.6% over the period. A positive accumulated result supports equity.
Conclusion
Cardinal Health's balance sheet profile remains vulnerable. Lower liabilities and capital accumulation are the main routes to improvement.
Annual Balance Sheet Cardinal Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
4.27 B | -358 M | -67 M | 92 M | 2.06 B | 3.99 B | 5.5 B | 7.25 B | 3.52 B | 3.18 B | 876 M | 1.11 B | 1.95 B | 620 M | 573 M |
Long Term Debt |
7.98 B | 4.66 B | 3.91 B | 4.74 B | 5.36 B | 6.76 B | 7.58 B | 8.01 B | 9.07 B | 4.95 B | 5.21 B | 3.17 B | 3.69 B | 2.42 B | 2.18 B |
Long Term Debt Current |
164 M | 117 M | 100 M | 102 M | 105 M | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | 10.5 B | 11 B | 12.1 B | 7.85 B | 6.64 B | 4.52 B | 5.25 B | 3.84 B | 3.63 B |
Total Current Liabilities |
38.9 B | 35.6 B | 33.7 B | 30.6 B | 27.6 B | 23.6 B | 24.1 B | 22.9 B | 21.2 B | 19.7 B | 17.2 B | 15.1 B | 14.6 B | 14.2 B | 13.4 B |
Total Liabilities |
- | - | - | - | - | - | 34.6 B | 33.9 B | 33.3 B | 27.6 B | 23.9 B | 19.6 B | 19.8 B | 18 B | 17 B |
Retained Earnings |
783 M | -286 M | -642 M | -280 M | 1.2 B | 1.17 B | 5.43 B | 4.64 B | 4.97 B | 6.42 B | 5.52 B | 4.77 B | 4.04 B | 4.09 B | 3.33 B |
Total Assets |
53.1 B | 45.1 B | 43.3 B | 43.9 B | 44.5 B | 40.8 B | 41 B | 40 B | 40.1 B | 34.1 B | 30.1 B | 26 B | 25.8 B | 24.3 B | 22.8 B |
Cash and Cash Equivalents |
3.87 B | 5.13 B | 4.08 B | 4.74 B | 3.41 B | 2.77 B | 2.53 B | 1.76 B | 6.88 B | 2.36 B | 4.62 B | 2.86 B | 1.9 B | 2.27 B | 1.93 B |
Book Value |
53.1 B | 45.1 B | 43.3 B | 43.9 B | 44.5 B | 40.8 B | 6.33 B | 6.06 B | 6.83 B | 6.57 B | 6.26 B | 6.4 B | 5.98 B | 6.24 B | 5.85 B |
Total Shareholders Equity |
-2.78 B | -3.21 B | -2.96 B | -882 M | 1.79 B | 1.79 B | 6.33 B | 6.06 B | 6.81 B | 6.55 B | 6.26 B | 6.4 B | 5.98 B | 6.24 B | 5.85 B |
All numbers in USD currency
Quarterly Balance Sheet Cardinal Health
| 2025-Q4 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
8.35 B | 7.14 B | 7.06 B | 4.22 B | 4.67 B | 3.54 B | 3.89 B | 4.71 B | 4.68 B | 4.69 B | 4.74 B | 4.75 B | 5.34 B | 5.35 B | 5.36 B | 5.36 B | 6.72 B | 6.73 B | 6.76 B | 6.76 B | 6.74 B | 7.36 B | 7.58 B | 7.58 B | 7.6 B | 8 B | 8.01 B | 8.01 B | 9.06 B | 9.07 B | 9.07 B | 9.07 B | 4.86 B | 4.92 B | 4.95 B | 4.95 B | 5.17 B | 5.23 B | 5.21 B | 5.21 B | 3.71 B | 3.16 B | 3.17 B | 3.17 B | 3.68 B | 3.69 B | 3.69 B | 3.69 B | 2.42 B | 2.41 B | 2.42 B | 2.42 B | 2.21 B | 2.2 B | 2.5 B | 2.48 B |
Retained Earnings |
1.46 B | 664 M | 283 M | 14 M | -289 M | -425 M | -654 M | -342 M | -560 M | -301 M | -280 M | -281 M | 1.24 B | 1.34 B | 1.2 B | 1.2 B | 1.26 B | 771 M | 1.17 B | 1.17 B | 449 M | 371 M | 5.43 B | 5.43 B | 5.23 B | 5.1 B | 4.64 B | 4.64 B | 5.85 B | 4.94 B | 4.97 B | 4.97 B | 4.6 B | 6.58 B | 6.42 B | 6.42 B | 5.97 B | 5.77 B | 5.52 B | 5.52 B | 5.1 B | 4.92 B | 4.77 B | 4.77 B | 4.45 B | 4.27 B | 4.04 B | 4.04 B | 4.49 B | 4.28 B | 4.09 B | 4.09 B | 3.68 B | 3.49 B | 3.33 B | 3.33 B |
Total Assets |
58.1 B | 49.9 B | 47 B | 43.1 B | 45.9 B | 46.6 B | 43.7 B | 43.4 B | 44.5 B | 43.4 B | 43.9 B | 42.1 B | 43.7 B | 43 B | 44.5 B | 44.5 B | 44.7 B | 41.7 B | 40.8 B | 40.8 B | 41 B | 39.2 B | 41 B | 41 B | 40.5 B | 40 B | 40 B | 40 B | 42.9 B | 41.9 B | 40.1 B | 40.1 B | 35 B | 34.4 B | 34.1 B | 34.1 B | 33.5 B | 31.2 B | 30.1 B | 30.1 B | 27.2 B | 25.7 B | 26 B | 26 B | 25 B | 23.8 B | 25.8 B | 25.8 B | 24.6 B | 24.8 B | 24.3 B | 24.3 B | 24.3 B | 23.2 B | 22.8 B | 22.8 B |
Cash and Cash Equivalents |
2.78 B | 3.33 B | 3.81 B | 2.87 B | 3.75 B | 4.6 B | 3.87 B | 3.99 B | 3.65 B | 3.49 B | 4.72 B | 2.36 B | 3.16 B | 2.46 B | 3.41 B | 3.41 B | 3.74 B | 2.75 B | 3.74 B | 2.75 B | 1.66 B | 1.21 B | 1.66 B | 1.21 B | 2.18 B | 2.04 B | 2.18 B | 2.04 B | 1.25 B | 1.18 B | 1.25 B | 1.18 B | 1.88 B | 2 B | 1.88 B | 2 B | 2.32 B | 2.97 B | 2.32 B | 2.97 B | 2.88 B | 2.47 B | 2.88 B | 2.47 B | 2.74 B | 2.75 B | 2.74 B | 2.75 B | 2.3 B | 2.44 B | 2.26 B | 2.44 B | 1.8 B | 2.01 B | 1.8 B | 2.01 B |
Book Value |
58.1 B | 49.9 B | 47 B | 43.1 B | 45.9 B | 46.6 B | 43.7 B | 43.4 B | 44.5 B | 43.4 B | 43.9 B | 42.1 B | 43.7 B | 43 B | 44.5 B | 44.5 B | 44.7 B | 41.7 B | 40.8 B | 40.8 B | 41 B | 39.2 B | 41 B | 41 B | 40.5 B | 40 B | 40 B | 40 B | 42.9 B | 41.9 B | 40.1 B | 40.1 B | 35 B | 34.4 B | 34.1 B | 34.1 B | 33.5 B | 31.2 B | 30.1 B | 30.1 B | 27.2 B | 25.7 B | 26 B | 26 B | 25 B | 23.8 B | 25.8 B | 25.8 B | 24.6 B | 24.8 B | 24.3 B | 24.3 B | 24.3 B | 23.2 B | 22.8 B | 22.8 B |
Total Shareholders Equity |
-2.88 B | -2.95 B | -2.92 B | -3.28 B | -3.36 B | -3.55 B | -3.61 B | -2.22 B | -2.21 B | -1.78 B | -709 M | -693 M | 1 B | 1.4 B | 1.79 B | 1.79 B | 1.97 B | 1.42 B | 1.79 B | 1.79 B | 999 M | 900 M | 6.33 B | 6.33 B | 6.04 B | 6.06 B | 6.06 B | 7.54 B | 7.6 B | 6.68 B | 6.81 B | 6.81 B | 6.32 B | 6.51 B | 6.55 B | 6.55 B | 6.71 B | 6.5 B | 6.26 B | 6.26 B | 6.1 B | 6.26 B | 6.4 B | 6.4 B | 6.59 B | 6.3 B | 5.98 B | 5.98 B | 6.54 B | 6.28 B | 6.24 B | 6.24 B | 5.93 B | 5.71 B | 5.85 B | 5.85 B |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Cardinal Health, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Medical distribution
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
AmerisourceBergen Corporation
ABC
|
- | -0.23 % | $ 37.5 B |  USA |
 |
PPD, Inc.
PPD
|
- | 0.13 % | $ 16.6 B | USA |
 |
Owens & Minor
OMI
|
- | - | $ 215 M | USA |
 |
Patterson Companies
PDCO
|
- | -0.87 % | $ 3 B | USA |
 |
Henry Schein
HSIC
|
$ 85.75 | 0.68 % | $ 10.4 B | USA |
 |
Prestige Consumer Healthcare
PBH
|
$ 50.22 | 0.54 % | $ 2.43 B | USA |
 |
McKesson Corporation
MCK
|
$ 856.19 | -1.08 % | $ 138 B | USA |